Loading clinical trials...
Loading clinical trials...
There is a need for more treatment options for patients with recurrent squamous cell cancer of the head and neck (SCCHN). These tumors usually have a variety of genetic defects that include disruption...
Bring this clarity to your next appointment.
Keep all your medical notes and next steps in one place.
Lead Sponsor
Introgen Therapeutics
NCT04099290 · Head and Neck Neoplasm, Carcinoma, Squamous Cell
NCT06912087 · Head and Neck Neoplasms, Carcinoma, Squamous Cell, and more
NCT04429542 · Head and Neck Squamous Cell Carcinoma, Squamous Cell Carcinoma of Anal Canal, and more
NCT04564989 · Oropharyngeal Squamous Cell Carcinoma, Carcinoma, Squamous Cell, and more
NCT05955924 · Non-melanoma Skin Cancer, Carcinoma, Squamous Cell, and more
University of Arkansas
Little Rock, Arkansas
Unversity of Colorado Cancer Center
Aurora, Colorado
University of Miami Hospital and Sylvester Comprehensive Cancer Center
Miami, Florida
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions